Dr. Noel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Washington, DC 20007Phone+1 202-444-2223
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of RochesterResidency, Internal Medicine, 2008 - 2011
- Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
- VA State Medical License 2021 - 2026
- DC State Medical License 2019 - 2024
- MD State Medical License 2022 - 2023
- NY State Medical License 2010 - 2020
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Start of enrollment: 2017 Oct 06
- A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer Start of enrollment: 2021 Mar 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanc...Nicole Libbey, Lindsey Gallagher, Jonathan Cantalino, Benjamin A Weinberg, Marcus S Noel
Journal of Gastrointestinal Cancer. 2024-06-01 - 1 citationsPhase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC).Benjamin A Weinberg, Hongkun Wang, Marcus S Noel, Aiwu R He, John L Marshall
International Journal of Radiation Oncology, Biology, Physics. 2024-02-01 - Evolving applications of liquid biopsies in gastrointestinal cancers.Peter Li, Christian Agbisit, Marcus Noel, Reetu Mukherji
Clinical Advances in Hematology & Oncology. 2024-01-31
Press Mentions
- Let’s Talk About: Pancreatic Cancer’s Impact on Black AmericansFebruary 4th, 2022
- ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GIJanuary 24th, 2022
- ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic CancerAugust 24th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: